Human Plasma IgG -Glycome Profiles Reveal a Proinflammatory Phenotype in Chronic Thromboembolic Pulmonary Hypertension.

Hypertension

Department of Cardiology (Z.-J.Z., T.-Y.L., Y.-P.Z., X.-Q.X., F.G., Y.-P.W., J.-Y.L., K.S., C.L., Z.-C.J.), State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Published: September 2023

AI Article Synopsis

  • The study investigates the role of IgG -glycosylation in chronic thromboembolic pulmonary hypertension (CTEPH) to understand its inflammatory mechanisms and identify potential new markers and therapies.
  • Researchers analyzed the plasma IgG -glycome in CTEPH patients, finding decreased IgG galactosylation associated with a proinflammatory state and strong connections to clinical markers like NT-proBNP.
  • This groundbreaking research is the first to map the IgG -glycome's proinflammatory phenotype in CTEPH, highlighting its potential as an indicator of inflammation and enhancing our understanding of the disease's glycomic mechanisms.

Article Abstract

Background: The pathological mechanism of chronic thromboembolic pulmonary hypertension (CTEPH) is not fully understood, and inflammation has been reported to be one of its etiological factors. IgG regulates systemic inflammatory homeostasis, primarily through its -glycans. Little is known about IgG -glycosylation in CTEPH. We aimed to map the IgG -glycome of CTEPH to provide new insights into its pathogenesis and discover novel markers and therapies.

Methods: We characterized the plasma IgG -glycome of patients with CTEPH in a discovery cohort and validated our results in an independent validation cohort using matrix-assisted laser desorption/ionization time of flight mass spectrometry. Thereafter, we correlated IgG -glycans with clinical parameters and circulating inflammatory cytokines in patients with CTEPH. Furthermore, we determined IgG -glycan quantitative trait loci in CTEPH to reveal partial mechanisms underlying glycan changes.

Results: Decreased IgG galactosylation representing a proinflammatory phenotype was found in CTEPH. The distribution of IgG galactosylation showed a strong association with NT-proBNP (N-terminal pro-B-type natriuretic peptide) in CTEPH. In line with the glycomic findings, IgG pro-/anti-inflammatory -glycans correlated well with a series of inflammatory markers and gene loci that have been reported to be involved in the regulation of these glycans or inflammatory immune responses.

Conclusions: This is the first study to reveal the full signature of the IgG -glycome of a proinflammatory phenotype and the genes involved in its regulation in CTEPH. Plasma IgG galactosylation may be useful for evaluating the inflammatory state in patients with CTEPH; however, this requires further validation. This study improves our understanding of the mechanisms underlying CTEPH inflammation from the perspective of glycomics.

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.123.21408DOI Listing

Publication Analysis

Top Keywords

igg -glycome
16
igg
12
plasma igg
12
proinflammatory phenotype
12
patients cteph
12
igg galactosylation
12
cteph
11
chronic thromboembolic
8
thromboembolic pulmonary
8
pulmonary hypertension
8

Similar Publications

Background/objective: In a subset of participants from the CALERIE Phase 2 study we evaluated the effects of 2y of ~25% Calorie Restriction (CR) diet on IgG N-glycosylation (GlycAge), plasma and complement C3 N-glycome as markers of aging and inflammaging.

Methods: Plasma samples from 26 participants in the CR group who completed the CALERIE2 trial and were deemed adherent to the intervention (~>10 % CR at 12 mo) were obtained from the NIA AgingResearchBiobank. Glycomic investigations using UPLC or LC-MS analyses were conducted on samples from baseline (BL), mid-intervention (12 mo) and post-intervention (24 mo), and changes resulting from the 2y CR intervention were examined.

View Article and Find Full Text PDF

Restructuring Biologically Assembled Binding Protein-Biopolymer Conjugates toward Advanced Materials.

ACS Appl Mater Interfaces

December 2024

Centre for Cell Factories and Biopolymers, Griffith Institute for Biomedicine and Glycomics, Griffith University, Nathan, QLD 4111, Australia.

Bacterial cell factories have been successfully engineered to efficiently assemble spherical polyhydroxybutyrate inclusions coated with functional proteins of interest. In these submicrometer-sized core-shell assemblies, proteins are bioconjugated to the polymer core, enabling bioengineering for uses as bioseparation resins, enzyme carriers, diagnostic reagents, and particulate vaccines. Here, we explore whether these functional protein-polymer assemblies could be restructured via dissolution and subsequent precipitation while retaining the functionality of the conjugated protein.

View Article and Find Full Text PDF
Article Synopsis
  • Knowledge gaps in understanding human immunity to Streptococcus pyogenes have slowed vaccine development, prompting researchers to establish a human challenge model to study this infection.
  • The study analyzed antibody responses in serum and saliva from participants, revealing that those who developed pharyngitis had strong serum IgG responses to vaccine antigens but weaker mucosal IgA responses.
  • The findings indicate that past exposure to the bacteria affects immune responses, underscoring the need to consider these complexities when evaluating potential vaccines in future trials.
View Article and Find Full Text PDF

Time-course RNA sequencing reveals high similarity in mRNAome between hepatic stellate cells activated by agalactosyl IgG and TGF-β1.

Funct Integr Genomics

November 2024

Department of Medical Laboratory Science, College of Medical Science and Technology, I-Shou University, No.8, Yida Road, Jiaosu Village, Yanchao District, Kaohsiung City, 82445, Taiwan.

Article Synopsis
  • This study investigates how agalactosyl IgG, a specific type of immunoglobulin G, affects the gene expression in hepatic stellate cells (HSCs), which play a critical role in liver fibrosis.
  • Researchers used RNA sequencing to track changes in mRNA levels after treating HSCs with agalactosyl IgG, noting significant gene expression alterations on day 5 post-treatment, which then decreased by day 11.
  • They identified a high similarity in gene expression profiles between agalactosyl IgG and TGF-β1 treatments, linking many differentially expressed genes (DEGs) to various liver conditions, revealing key genes like CCL5 and FAS that are involved in liver
View Article and Find Full Text PDF

Background: A previous study demonstrated that N-glycosylation profiles of IgG are associated with subclinical atherosclerosis in a British population. However, the generalisability of this finding to other ethnic groups remains to be investigated, and it has yet to account for additional traditional atherosclerotic risk factors. The present study, thus, aims to explore IgG N-glycosylation profiles in Han Chinese with atherosclerosis, and their potential role in atherosclerosis, while controlling for traditional atherosclerotic risk factors.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!